We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Mitchell Smith

Mitchell R. Smith MD, PhD

Director Lymphoid Malignancy Program, Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio

Dr. Smith is the Director of the Lymphoid Malignancy Program Service in the Taussig Cancer Institute of the Cleveland Clinic. A graduate of Stanford University, Smith earned his MD and PhD at Case Western Reserve University in Cleveland. He completed his fellowship in medical oncology and biomedical research through the clinical scholars program at Memorial Sloan-Kettering Cancer Center in New York City. After serving as Assistant Professor in the Department of Medical Oncology at Wayne State University in Detroit, MI, he joined Fox Chase Cancer Center in 1993, where he remained as Director of the Lymphoma Program until 2012. At that time he moved to his current position at the Cleveland Clinic, where he is also Professor of Medicine in the Lerner Research Institute.